Prudential Financial’s Bionano Genomics BNGO Stock Holding History

Prudential Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.7K	Buy	31,600 +3,600	+13%	+$4.34K	﹤0.01%	2454
2026 Q1	$32.8K	Buy	+28,000	New	+$35.9K	﹤0.01%	2354
2024 Q3	–	Sell	-238	Closed	-$9.7K	–	2717
2024 Q2	$9.7K	Buy	+238	New	+$13.1K	﹤0.01%	2679
2024 Q1	–	Sell	-205	Closed	-$23.2K	–	2680
2023 Q4	$23.2K	Buy	+205	New	+$21.4K	﹤0.01%	2609
2023 Q2	–	Sell	-35	Closed	-$23.5K	–	2627
2023 Q1	$23.5K	Hold	35	–	–	﹤0.01%	2559
2022 Q4	$31K	Hold	35	–	–	﹤0.01%	2540
2022 Q3	$39K	Hold	35	–	–	﹤0.01%	2576
2022 Q2	$29K	Hold	35	–	–	﹤0.01%	2621
2022 Q1	$55K	Hold	35	–	–	﹤0.01%	2568
2021 Q4	$63K	Sell	35 -3	-8%	-$8.02K	﹤0.01%	2596
2021 Q3	$125K	Buy	38 +1	+3%	+$3.5K	﹤0.01%	2514
2021 Q2	$162K	Buy	+37	New	+$146K	﹤0.01%	2474

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Prudential Financial's BNGO Position: Q2 2026 in Review

Prudential Financial increased its Bionano Genomics (BNGO) stake by 13% in Q2 2026, buying an estimated $4.34K and bringing the position to 31,600 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2454.

Prudential Financial first reported a position in BNGO in Q2 2021 and has held it in 12 quarters since. The position peaked at $162K in Q2 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

Prudential Financial held 31,600 shares of Bionano Genomics worth $35.7K as of Q2 2026.
Prudential Financial bought 3,600 Bionano Genomics shares in Q2 2026, an estimated $4.34K.
Bionano Genomics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2454 holding.
Prudential Financial first reported a position in Bionano Genomics in Q2 2021 and has held it in 12 quarters since.
Prudential Financial's Bionano Genomics position peaked at $162K in Q2 2021.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.